Clinical applications of telomerase in cancer treatment

Drug Resistance Updates

Volumn 3, Issue 3, 2000, Pages 161-170

  Faraoni, Isabella ^a   Bonmassar, Enzo ^a,b   Graziani, Grazia ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE; TUMOR MARKER; ZIDOVUDINE;

CANCER CELL; CANCER DIAGNOSIS; CANCER RESISTANCE; CHEMOSENSITIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TELOMERE;

EID: 0033852802     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1054/drup.2000.0139     Document Type: Article

References (68)

1. The human telomere terminal transferase enzyme is a ribonucloprotein that synthesizes TTAGGG repeats
2. Telomerase and maintenance of chromosome ends
3. Cellular senescence and cancer
4. Human telomeres contain two distinct Myb-related proteins, TRF-1 and TRF-2
5. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres
6. TIN2, a new regulator of telomere length in human cells
7. Control of human telomere lenght by TRF1 and TRF2
8. Mammalian telomeres end in a large duplex loop
9. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines
10. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues
11. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP)
12. Detection of telomerase activity in human carcinomas using trap-ELISA method: Correlation with hTR and hTERT expression
13. Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections
14. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas
15. Telomerase activity in human proliferative breast lesions
16. Applications of telomerase research in the fight against cancer
17. Telomerase assay for differentiating between malignancy-related and nonmalignant ascites
18. Detection of ovarian cancer cells: Comparison of a telomerase assay and cytologic examination
19. Clinical significance of telomerase activity in the non-cancerous epithelial region of oesophageal squamous cell carcinoma
20. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients
21. Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro
22. Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: In vitro studies with fresh human tumor samples
23. Correlating telomerase activity levels with human neuroblastoma
24. Comparative genomic hybridization and telomerase activity analysis identify two biologically different groups of 4s neuroblastomas
25. Telomerase activity distinguishes between neuroblastomas with good and poor prognosis
26. Telomerase activity as a prognostic indicator in stage I lung cancer
27. Correlation of clinical features and telomerase activity in human gliomas
28. Telomerase activity and prognosis in primary breast cancers
29. Telomerase activity and survival of patients with node-positive breast cancer
30. Resistance to apoptosis in human cells conferred by telomerase function and telomere stability
31. Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis
32. Toward identifying a cellular determinant of telomerase repression
33. How does radiation kill cells?
34. Telomeres and telomerase in normal and malignant haematopoietic cells
35. Telomerase targeting in cancer treatment: New developments
36. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death
37. Cellular delivery of peptide nucleic acids and inhibition of human telomerase
38. Telomerase inhibition by peptide nucleic acids reverses 'immortality' of transformed human cells
39. Inhibition of human telomerase by 2'-O-methyl-RNA
40. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells
41. Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells
42. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA
43. 2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells
44. Inhibition of telomerase limits the growth of human cancer cells
45. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells
46. Irreversible telomere shortening by 3'-azido-2',3'-dideoxythymidine (AZT) treatment
47. Telomerase from human leukemia cells: Properties and its interaction with deoxynucleotide analogues
48. Blockade of telomerase function in various cells
49. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine
50. The development of telomerase inhibitors: The G-quartet approach
51. Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells
52. Human telomerase inhibition by substituted acridine derivatives
53. 2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase
54. Telomere loss in cells treated with cisplatin
55. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2
56. The Wilms' tumor I suppressor gene represses transcription of the human telomerase reverse transcriptase gene
57. Telomerase, telomerase, and myc. An update
58. Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells
59. Isothiazolone derivatives selectively inhibit telomerase from human and rat cancer cells in vitro
60. Design, synthesis and evaluation of human telomerase inhibitors based upon a tetracyclic structural motif
61. 9-Hydroxyellipticine inhibits telomerase activity in human pancreatic cancer cells
62. Telomerase activity in skeletal sarcomas
63. Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: Correlation with grade, histology, and proliferative activity
64. p53 Deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis
65. Enzymatic activity of endogenous telomerase associated with intact nuclei from human leukemia CEM cells
66. Telomere length changes in patients undergoing hematopoietic stem cell transplantation
67. Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse
68. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes